157 related articles for article (PubMed ID: 36500383)
1. Anticancer Activity of (±)-Kusunokinin Derivatives towards Cholangiocarcinoma Cells.
Rattanaburee T; Sermmai P; Tangthana-Umrung K; Thongpanchang T; Graidist P
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500383
[TBL] [Abstract][Full Text] [Related]
2.
Rattanaburee T; Chompunud Na Ayudhya C; Thongpanchang T; Tipmanee V; Graidist P
Molecules; 2023 Oct; 28(21):. PubMed ID: 37959760
[TBL] [Abstract][Full Text] [Related]
3. Anticancer activity of synthetic (±)-kusunokinin and its derivative (±)-bursehernin on human cancer cell lines.
Rattanaburee T; Thongpanchang T; Wongma K; Tedasen A; Sukpondma Y; Graidist P
Biomed Pharmacother; 2019 Sep; 117():109115. PubMed ID: 31220743
[TBL] [Abstract][Full Text] [Related]
4. (-)-Kusunokinin and piperloguminine from Piper nigrum: An alternative option to treat breast cancer.
Sriwiriyajan S; Sukpondma Y; Srisawat T; Madla S; Graidist P
Biomed Pharmacother; 2017 Aug; 92():732-743. PubMed ID: 28586745
[TBL] [Abstract][Full Text] [Related]
5. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells.
Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L
Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588
[TBL] [Abstract][Full Text] [Related]
6. (-)-Kusunokinin inhibits breast cancer in N-nitrosomethylurea-induced mammary tumor rats.
Tedasen A; Dokduang S; Sukpondma Y; Lailerd N; Madla S; Sriwiriyajan S; Rattanaburee T; Tipmanee V; Graidist P
Eur J Pharmacol; 2020 Sep; 882():173311. PubMed ID: 32619673
[TBL] [Abstract][Full Text] [Related]
7. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE.
Wang Z; Tang X; Zhang Y; Qi R; Li Z; Zhang K; Liu Z; Yang X
Biomed Pharmacother; 2012 Apr; 66(3):161-6. PubMed ID: 22425181
[TBL] [Abstract][Full Text] [Related]
8. Effects of trans-(±)-kusunokinin on chemosensitive and chemoresistant ovarian cancer cells.
Mad-Adam N; Rattanaburee T; Tanawattanasuntorn T; Graidist P
Oncol Lett; 2022 Feb; 23(2):59. PubMed ID: 34992691
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of topoisomerase IIα and induction of DNA damage in cholangiocarcinoma cells by altholactone and its halogenated benzoate derivatives.
Kitdumrongthum S; Reabroi S; Suksen K; Tuchinda P; Munyoo B; Mahalapbutr P; Rungrotmongkol T; Ounjai P; Chairoungdua A
Biomed Pharmacother; 2020 Jul; 127():110149. PubMed ID: 32344256
[TBL] [Abstract][Full Text] [Related]
10. Anticancer Activity of Fucoidan via Apoptosis and Cell Cycle Arrest on Cholangiocarcinoma Cell.
Chantree P; Na-Bangchang K; Martviset P
Asian Pac J Cancer Prev; 2021 Jan; 22(1):209-217. PubMed ID: 33507701
[TBL] [Abstract][Full Text] [Related]
11. Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways.
Prakobwong S; Gupta SC; Kim JH; Sung B; Pinlaor P; Hiraku Y; Wongkham S; Sripa B; Pinlaor S; Aggarwal BB
Carcinogenesis; 2011 Sep; 32(9):1372-80. PubMed ID: 21325634
[TBL] [Abstract][Full Text] [Related]
12. Benzoyltyramine Alkaloids Atalantums A-G from the Peels of Atalantia monophylla and Their Cytotoxicity against Cholangiocarcinoma Cell Lines.
Sribuhom T; Boueroy P; Hahnvajanawong C; Phatchana R; Yenjai C
J Nat Prod; 2017 Feb; 80(2):403-408. PubMed ID: 28140592
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines.
Hahnvajanawong C; Boonyanugomol W; Nasomyon T; Loilome W; Namwat N; Anantachoke N; Tassaneeyakul W; Sripa B; Namwat W; Reutrakul V
World J Gastroenterol; 2010 May; 16(18):2235-43. PubMed ID: 20458760
[TBL] [Abstract][Full Text] [Related]
14. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents.
Srijiwangsa P; Ponnikorn S; Na-Bangchang K
BMC Pharmacol Toxicol; 2018 Jun; 19(1):32. PubMed ID: 29914576
[TBL] [Abstract][Full Text] [Related]
15. Ethanolic extract of Ya-nang (
Samankul A; Senawong G; Swatsitang P; Sripa B; Phaosiri C; Kanokmedhakul S; Senawong T
PeerJ; 2022; 10():e14518. PubMed ID: 36540797
[TBL] [Abstract][Full Text] [Related]
16. Anti-Proliferative Effects of Compound A and Its Effect in Combination with Cisplatin in Cholangiocarcinoma Cells.
Junking M; Rattanaburee T; Panya A; Budunova I; Haegeman G; Yenchitsomanus PT
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2673-2681. PubMed ID: 32986368
[TBL] [Abstract][Full Text] [Related]
17. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.
Yothaisong S; Dokduang H; Techasen A; Namwat N; Yongvanit P; Bhudhisawasdi V; Puapairoj A; Riggins GJ; Loilome W
Tumour Biol; 2013 Dec; 34(6):3637-48. PubMed ID: 23832540
[TBL] [Abstract][Full Text] [Related]
18. Gambogic Acid Inhibits Wnt/β-catenin Signaling and Induces ER Stress-Mediated Apoptosis in Human Cholangiocarcinoma.
Suksen K; Janpipatkul K; Reabroi S; Anantachoke N; Reutrakul V; Chairoungdua A; Thongon N; Bhukhai K
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1913-1920. PubMed ID: 34181351
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Ibuprofen, Naproxen and Diclofenac on cell Apoptosis, Cell Proliferation and Histology Changes in Human Cholangiocarcinoma Cell Lines.
Leksomboon R; Kumpangnil K; Pangjit K; Udomsuk L
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1351-1358. PubMed ID: 35485696
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents.
Samatiwat P; Prawan A; Senggunprai L; Kukongviriyapan U; Kukongviriyapan V
Tumour Biol; 2016 Aug; 37(8):11495-507. PubMed ID: 27015836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
